The CEO of Emergent BioSolutions, the company that ruined 15 million doses of Johnson & Johnson’s COVID-19 vaccine, sold more than $10 million worth of his stock in the company before the price fell. Robert Kramer sold the stocks in January and early February, right before the price fell on February 19 after the company’s published financial report. The price has since dropped from $125 a share to $62, a more than 50% drop, the Post reported.